Bridgewest Group launches new sterile injectable CDMO NovaCina

Lonza and ABL Bio collaborate on development and manufacture of new bispecific antibody product

Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution

Israeli researchers develop an effective drug to prevent muscle diseases

The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.

EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company

EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging

Getinge to boost scalability and deepen healthcare access in India

Getinge has a strong market share in India within several product segments

HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData

SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development

Lonza completes drug product manufacturing line in Visp

This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering

MPP signs sublicences with Aurobindo, Cipla and Viatris to produce generic versions of HIV prevention medicine

Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers

Medanta launches women and child care services in Gurugram

Women of all ages will get round-the-clock access to comprehensive treatment

OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes

This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India